Sympathetic hyperactivity in hypertensive chronic kidney disease patients is reduced during standard treatment

Hypertension. 2007 May;49(5):e27; author reply e28. doi: 10.1161/HYPERTENSIONAHA.107.087908. Epub 2007 Mar 5.
No abstract available

Publication types

  • Comment
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin II Type 1 Receptor Blockers / therapeutic use
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Chronic Disease
  • Humans
  • Hypertension / complications*
  • Hypertension / drug therapy*
  • Kidney Diseases / etiology*
  • Kidney Diseases / physiopathology*
  • Sympathetic Nervous System / drug effects
  • Sympathetic Nervous System / physiopathology*

Substances

  • Angiotensin II Type 1 Receptor Blockers
  • Angiotensin-Converting Enzyme Inhibitors